Parties negotiating terms of definitive agreement
Agreement intended to launch New Rise Australia as a SAF and HVO platform driven by XCF's patent-pending site design and configuration
Agreement expected to include equity stake, license fees, and exclusive rights to the Australian market
Intended partnership in line with announced strategy regarding international expansion
Cardio Shield, developed by Apollo Research, emerges as the leading cardiovascular supplement of 2025 with a clinically inspired, natural formula designed to support blood pressure, circulation, and heart function - backed by real user results, scientific validation, and a 180-day risk-free guarantee.
Read MoreRosie AGI™ (Recursive Ontology Symbolic Inference Entity) Operates at Human-Level Energy Efficiency, Requires No GPUs, and Runs on Phones, Watches, and Smartcards
Read More
This strategic investment will catalyze transformative infrastructure improvements and pioneering environmental enhancements led by evidence based-design with a biophilic lens - advancing public health, strengthening community resilience and fueling long-term economic growth for Texas
Read More
Designed to support daily energy, testosterone balance, and confidence through science-backed natural ingredients, Tropical Rise introduces a wellness-forward approach to men's health in 2025.
Read More
Newly published wellness guide explores how Nucentix VMAX blends 14 science-backed botanical ingredients into a structured daily system for circulation, energy, and male vitality support - without synthetic alternatives.
Read More
A data-backed analysis of AquaBurn's role in supporting natural thermogenesis, metabolic energy balance, and brown adipose tissue activation for long-term wellness strategies in 2025.
Read More
Institute for Natural Healing champions a science-backed, transparent approach to natural aging support in 2025, spotlighting the WarBurg Method's renewed role in cellular wellness and integrative health guidance.
Read More
Aerospace medical research originally developed to protect astronauts in space is now inspiring a new class of natural wellness solutions - offering consumers light-based pain relief, cognitive support protocols, and antioxidant-rich cellular protectants in 2025.
Read More
Grounded in science-backed meal timing, cognitive wellness strategies, and natural supplement integration, the RFK Method delivers a structured approach to help adults over 60 support metabolic health, energy stability, and long-term lifestyle transformation - without reliance on pharmaceuticals.
Read More
Independent Healthcare Technology Research Firm Identifies Next-Generation Leaders in Revenue Cycle Management, Scoring Firms on Ten Strategic Performance Indicators for Exceptional Growth Potential
Read More
KITON Segment Surpasses 1 Million Views as New to The Street Continues to Dominate Financial Media Across Broadcast, Digital, and Outdoor Platforms
Read More
June 28 is dedicated to reviewing insurance policies, understanding and learning about coverage options, and ensuring comprehensive protection for individuals and businesses
Read More
Lon G. von Hurwitz, who will serve as chief strategist and senior advisor, brings 30-plus years of leadership experience in healthcare innovation, marketing, and public health initiatives and will guide efforts to bring the smart medication delivery technology to market in early 2026.
Read MoreCanalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogs
Jaguar is exploring the possibility of approval of Canalevia for treatment of general diarrhea in dogs in the EU based on the statistically significant data from a completed study
Diarrhea is one of the most common reasons owners bring their dog to the veterinarian and the second most common reason for visits to the veterinary emergency hospital, yet there are currently no FDA-approved drugs to treat general diarrhea in dogs
Company strategy: In discussions with multiple potential animal health company partners to collaborate to bring Canalevia to regulatory approval and commercialization for general diarrhea globally
Read More
Manufacturing in Michigan Accelerates Ondas' Delivery Timelines for Major Programs, Secures Domestic Supply Chains Resilience, Opens Doors to Growing Opportunities in U.S. Defense and Security Markets with NDAA-Compliant, Made-In-America Drones, and Strengthens Export Readiness to U.S. Allies
Detroit Manufacturing Systems (DMS) Brings Industrial Scale Proven Excellence in U.S. Manufacturing with Speed, Cost Efficiency, and Resiliency
Partnership is Expected to Benefit from Policies Outlined in the Trump Administration's Recent Unleashing American Drone Dominance Executive Order
Working Together, Ondas and DMS Aim to Ensure the U.S. Leads the World in Autonomous Drone Manufacturing, Deployment, and Regulatory Innovation
Read More
The ‘Make America Healthy Again' initiative challenges pharmaceutical influence, promotes access to natural therapies, and proposes regulatory changes to FDA oversight, food safety, and vaccine review protocols.
Read MoreReverse Split Becomes Effective Friday, June 27, 2025
Shareholder- and Board-Approved Action Reduces Shares Outstanding to 1.4 million from 13.9 million, Expected to Ensure Continued Compliance with Nasdaq Listing Requirements
Read More